Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.54M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$2.52M
-
Value change
-
+$1.83M
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$1.64
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2019
26 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2019.
IGC Pharma, Inc. - COM NEW (IGC) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.54M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (454K shares), Carroll Financial Associates, Inc. (215K shares), GEODE CAPITAL MANAGEMENT, LLC (199K shares), DEARBORN PARTNERS LLC (103K shares), Anson Funds Management LP (94.4K shares), Creative Planning (64K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (53.3K shares), Virtu Financial LLC (51.9K shares), BANK OF MONTREAL /CAN/ (45K shares), and JANE STREET GROUP, LLC (44.8K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.